Anticoagulant Drugs

Mojca Božič-Mijovski

Please use this identifier to cite or link to this item: http://localhost:8080/xmlui/handle/123456789/147905

Full metadata record

DC Field	Value	Language
dc.contributor.author	Mojca Božič-Mijovski
dc.date.accessioned	2022-05-03T09:54:11Z	-
dc.date.available	2022-05-03T09:54:11Z	-
dc.date.issued	2018
dc.identifier.isbn	9781789236224 9781789236231
dc.identifier.uri	http://localhost:8080/xmlui/handle/123456789/147905	-
dc.language.iso	eng
dc.publisher	IntechOpen
dc.relation.isbasedon	10.5772/intechopen.70971
dc.relation.uri	https://www.intechopen.com/books/anticoagulant-drugs
dc.rights.uri	CC BY-NC-ND (姓名標示-非商業性-禁止改作)
dc.source	DOAB
dc.subject.classification	Therapeutics. Pharmacology
dc.subject.other	mouse model
dc.subject.other	hDPP4
dc.subject.other	MERS-CoV
dc.subject.other	pseudotyped virus
dc.subject.other	authentic virus
dc.subject.other	Middle East Respiratory Syndrome Virus
dc.subject.other	MERS-CoV
dc.subject.other	neutralizing monoclonal antibodies
dc.subject.other	MERS-CoV
dc.subject.other	MERS-CoV nucleocapsid protein
dc.subject.other	murine CD8+ T cell epitope
dc.subject.other	MVA vaccine
dc.subject.other	MERS-CoV
dc.subject.other	mechanism of action
dc.subject.other	small-molecule inhibitor
dc.subject.other	Drivers
dc.subject.other	MERS-CoV
dc.subject.other	Qatar
dc.subject.other	MERS-CoV
dc.subject.other	RBD
dc.subject.other	mutation
dc.subject.other	peptide
dc.subject.other	neutralizing antibody
dc.subject.other	combination
dc.subject.other	MERS-CoV
dc.subject.other	inflammation
dc.subject.other	pyroptosis
dc.subject.other	complement
dc.subject.other	MERS-CoV
dc.subject.other	fusion inhibitor
dc.subject.other	peptide
dc.subject.other	cell–cell fusion
dc.subject.other	HKU4
dc.subject.other	coronaviruses
dc.subject.other	SARS-CoV
dc.subject.other	MERS-CoV
dc.subject.other	spike proteins
dc.subject.other	animal model
dc.subject.other	prevention and treatment
dc.subject.other	Coronavirus
dc.subject.other	MERS-CoV
dc.subject.other	spike protein
dc.subject.other	receptor-binding domain
dc.subject.other	vaccines
dc.subject.other	therapeutics
dc.subject.other	lipidomics
dc.subject.other	UHPLC–MS
dc.subject.other	HCoV-229E
dc.subject.other	MERS-CoV
dc.subject.other	Middle East respiratory syndrome coronavirus
dc.subject.other	severe acute respiratory syndrome coronavirus
dc.subject.other	coronavirus spike glycoprotein
dc.subject.other	vaccine platforms
dc.subject.other	correlates of immunity
dc.subject.other	animal models
dc.subject.other	Coronavirus
dc.subject.other	MERS-CoV
dc.subject.other	receptor-binding domain
dc.subject.other	therapeutic antibodies
dc.subject.other	nanobodies
dc.subject.other	cross-neutralization
dc.subject.other	MERS-CoV
dc.subject.other	camels
dc.subject.other	vaccines
dc.subject.other	One Health
dc.subject.other	MERS-CoV
dc.subject.other	transmission
dc.subject.other	pathogenesis
dc.subject.other	host factors
dc.subject.other	DPP4
dc.subject.other	MERS-coronavirus
dc.subject.other	transmission
dc.subject.other	rabbits
dc.subject.other	n/a
dc.title	Anticoagulant Drugs
dc.type	電子教科書
dc.classification	醫學類
Theme:	教科書-醫學類

Files in This Item:

There are no files associated with this item.

Show simple item record

Taiwan MOOC OERs

Open Educational Resources (OER) are free and openly licensed educational materials that can be used for teaching, learning, research, and other purposes.